Company Filing History:
8 out of 13 
3 out of 9 
2 out of 3 Years Active: 2013-2025
Title: Zonghai Li: Innovator in Genetic Engineering and Cancer Treatment
Introduction
Zonghai Li is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of genetic engineering and cancer treatment. With a total of 16 patents to his name, he has made remarkable advancements that have the potential to revolutionize therapeutic approaches in oncology.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Genetically engineered cell and application thereof." This invention discloses a genetically engineered cell that expresses an exogenous receptor specifically binding to a target antigen and exogenous CCL21. The cell is capable of further expressing an IL-7R binding protein or exogenous IL-7, promoting cell proliferation. Additionally, the patent includes an expression construct comprising an exogenous CCL21 expression cassette, a vector containing the same, a virus, and a pharmaceutical composition comprising the engineered cell. This invention has significant applications in the preparation of drugs aimed at inhibiting tumors or pathogens. Another notable patent is "Method and composition for treating tumors," which provides a composition of immune effector cells and a treatment kit that includes an initial and subsequent dose of these cells.
Career Highlights
Zonghai Li has worked with notable organizations such as Crage Medical Co., Limited and the Shanghai Cancer Institute. His work in these institutions has allowed him to apply his innovative ideas in practical settings, contributing to advancements in medical technology and cancer treatment.
Collaborations
Throughout his career, Zonghai Li has collaborated with esteemed colleagues, including Huamao Wang and Hua Jiang. These partnerships have fostered a collaborative environment that enhances research and development in their respective fields.
Conclusion
Zonghai Li's contributions to genetic engineering and cancer treatment exemplify the impact of innovation in medicine. His patents and collaborative efforts continue to pave the way for new therapeutic strategies that hold promise for improving patient outcomes.